Author's correction Open Access
http://instance.metastore.ingenta.com/content/10.2807/1560-7917.ES.2022.27.17.220428c
Like 0
This item has no PDF Download
-
Author's correction for Euro Surveill. 2022;27(16)
-
View Affiliations Hide AffiliationsCorrespondence:Eurosurveillance editorial teameurosurveillance ecdc.europa.eu
-
View Citation Hide Citation
Citation style for this article: . Author's correction for Euro Surveill. 2022;27(16). Euro Surveill. 2022;27(17):pii=220428c. https://doi.org/10.2807/1560-7917.ES.2022.27.17.220428c
- Previous Article
- Table of Contents
- Next Article
There is no abstract available.
© 
This work is licensed under a Creative Commons Attribution 4.0 International License.
This work is licensed under a Creative Commons Attribution 4.0 International License.
Closure
This is a corrected article applying to the following content:
Vaccine-induced and naturally-acquired protection against Omicron and Delta symptomatic infection and severe COVID-19 outcomes, France, December 2021 to January 2022
Full text loading...
Comment moderation successfully completed